Principal Scientist - HEOR

Designs and runs epidemiological projects and studies. Collect and analyze data using targeted and systematic large data methods, including developing data collection criteria, collection tools, performing literature searches, and abstracting relevant data. Designs, develops and implements multiple projects to using disease(s) or product(s) specific evidence to contribute to clinical strategy, value assessment and market access. Contributes to the creation of department vision and goals. Develop written materials (reports, manuscripts, presentations) for presenting project results. Participate and effectively communicate in internal team discussions and in meetings with external stakeholders and clients. Work closely with the product planning, development and clinical lead to be responsible for population prevalence and incidence content. Collaborates with internal business partners to meet the evidence needs of external consumers. May be asked to perform other project-related and infrastructure activities such as: recruiting experts for meetings, advisory groups, or panels; contributing to or reviewing proposals; assisting with problem-solving; researching potential solutions, manage vendors.

According to JobzMall, the average salary range for a Principal Scientist - HEOR in 12780 El Camino Real, San Diego, CA 92130, USA is approximately $120,000 - $150,000 per year. This salary range may vary depending on the experience and qualifications of the individual, as well as the size and scope of the organization they are employed by.

Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD). The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids.